纳尔特雷克松预治疗对胺激素诱导的谷氨酸活性和抑郁症状的影响:一项随机交叉研究
Luke A Jelen1,2, David J Lythgoe3, James M Stone4,5
1The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. luke.jelen@kcl.ac.uk.
Nature medicine
|July 24, 2025
概括
阿片类药物系统影响了胺对谷氨酸的作用,以及它在严重抑郁症中具有抗抑郁作用. 一种阿片类药物阻断剂的纳尔特雷减少了胺对大脑谷氨酸水平和抑郁症状的影响.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型抑郁症 (MDD) 是全球导致残疾的主要原因.
- 胺显示出快速的抗抑郁作用,但其精确的机制仍在调查中.
- 在胺胺的作用中,谷氨酸和阿片类系统之间的相互作用尚未完全理解.
研究的目的:
- 调查阿片类药物系统在调节凯타민在MDD中的谷氨酸效应中的作用.
- 为了评估纳尔特雷克松是否会影响大脑谷氨酸水平和抗抑郁药反应中胺胺诱导的变化.
主要方法:
- 这是一项双盲交叉研究,涉及26名患有MDD的成年人.
- 参与者在静脉注射胺输注之前接受了口服纳尔特雷克松或安慰剂.
- 使用功能性磁共振光谱学 (fMRS) 在前带带皮质中测量大脑的谷氨酸活性.
- 使用蒙哥马利-阿斯伯格抑郁症评分表 (MADRS) 评估抑郁症状.
主要成果:
- 纳尔特雷克松显著减弱了前带皮质皮质中谷氨酸+谷氨酸与N-乙酸比率的胺诱导的增加.
- 纳尔特雷克松也减轻了MADRS得分的降低在基他胺后的第一天.
- 对于fMRS和MADRS发现均观察到统计学意义.
结论:
- 阿片类药物系统在调节对胺的急性谷氨酸反应方面发挥着重要作用.
- 阿片类药物系统调节会影响胺的立即抗抑郁作用.
- 了解这些相互作用可能会为抑郁症的新疗法策略提供信息.
相关概念视频
01:27CNS Depressants: Alcohol and Nicotine
360
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
360
01:27Phase I Reactions: Reductive Reactions
272
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
272
01:23Antidepressant Drugs: MAOIs and Other Agents
358
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
358